The researchers
tested their theory by orally administering a drug that inhibits DNA - PK and found that,
in addition to preventing weight gain
in the
mice, the inhibitor drug boosted mitochondrial content
in skeletal muscle, increased aerobic fitness
in obese and middle aged
mice, and reduced the incidence of obesity and type - 2 diabetes.